Warren Averett Asset Management, LLC Viking Therapeutics, Inc. Transaction History
Warren Averett Asset Management, LLC
- $8.88 Billion
- Q2 2025
A detailed history of Warren Averett Asset Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 40,906 shares of VKTX stock, worth $1.63 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
40,906
Previous 41,984
2.57%
Holding current value
$1.63 Million
Previous $1.01 Million
7.01%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding VKTX
# of Institutions
448Shares Held
66.9MCall Options Held
7.9MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$405 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$240 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$150 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.25MShares$129 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$125 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.06B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...